Skip to content

Fetal Endoscopic Surgery for Spina Bifida

Fetal Endoscopic Surgery for Spina Bifida

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03315637
Acronym
FESSB
Enrollment
50
Registered
2017-10-20
Start date
2015-01-31
Completion date
2024-12-31
Last updated
2017-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chiari Malformation Type 2, Congenital Abnormality, Fetal Disease, Hydrocephalus, Myelomeningocele, Neural Tube Defects, Spina Bifida, Open, Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus

Brief summary

This study aims to assess the feasibility to perform a fetoscopic prenatal repair of an open neural tube defect, and secondly to assess the maternal, fetal and neonatal outcomes.

Detailed description

Introduction: Spina bifida is a congenital malformation characterized by a failure in neural tube closure. Unprotected fetal neural tissue at the spine level undergoes not only progressive neurodegeneration in spinal cord, but also the impairment in brain development, hindbrain herniation or Chiari II malformation probably due to pressure disturbances resulting from a continuous leakage of cerebrospinal fluid through the defect. The neurological consequences at birth are irreversible and sometimes devastating, including paraplegia, sphincter urinary and fecal incontinence, hydrocephalus, cranial nerve disturbances, respiratory problems and death due to spinal cord injury and brain maldevelopment. Intrauterine fetal open repair of the defect has proved to improve hindbrain herniation and decrease the need of cerebrospinal shunting. Hypothesis: The investigators hypothesize that minimally invasive surgery of spina bifida is feasible and may minimize surgical aggression and obstetrical complications, with similar neonatal and neurological results. Intervention: In this study the investigators propose a fetoscopic skin closure technique. After a maternal laparotomy the uterus is exteriorized, the amniotic cavity is accessed by fetoscopic approach. The placode is dissected from the surrounding tissue and dropped into the opened spinal canal, untethered. Part of the cystic tissue is resected. The edges are then closed to the midline. Follow up: After surgery patients are followed up at the Fetal Medicine Unit every one or two weeks. The mode of delivery is decided according to obstetric criteria. Neonates will be examined at birth, and followed up regularly at least until 30 months. Patients are lifetime followed up by our Multidisciplinary myelomeningocele (MMC) Committee that comprises professionals from the Spina Bifida Unit, Neonatologists, Pediatric Surgeons, Pediatric Urologist, Pediatric Orthopedic Surgeons, Radiologists, Rehabilitation, Pathologists, Pediatric Neurosurgeons, Obstetricians and Fetal Therapists.

Interventions

PROCEDUREFetoscopic repair of spina bifida

Fetoscopic intrauterine repair of open spina bifida

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Maternal age \> 18 years old * Singleton pregnancy * Gestational age between 18 0/7 weeks and 26 6/7 weeks * Isolated neural tube defect between T1 and S1 * Cerebellar herniation (Chiari type II)

Exclusion criteria

* Fetal anomalies non related to neural tube defect (NTD) including chromosomal abnormalities * Body mass index \> 35 kg/m2 * Maternal disorders contraindicating surgery * Genetic anomalies with poor prognosis * Sever kyphosis (\>30º)

Design outcomes

Primary

MeasureTime frameDescription
Capability to achieve successful closure of the neural tube defect by fetoscopic surgery (yes/no)Time of procedure (day 0)Binary variable (yes/no) describing if the neural tube defect has been successfully closed, (placode dissected and dropped into the open spinal canal, cystic tissue resected and edges closed to the midline), by fetoscopic surgery, and without conversion to open surgery

Secondary

MeasureTime frameDescription
Operating time (minutes)Time of procedure (day 0)Time between the skin opening and skin closure
Fetoscopy time (minutes)Time of procedure (day 0)Time between the introduction of the first cannula and the removal of the last cannula
Hospital stay (days)Between procedure and delivery, up to 21 weeksTime between hospital admission and discharge

Other

MeasureTime frameDescription
Premature rupture of membranes (PROM) (yes/no)Between the procedure and 37 weeks of pregnancy (18 weeks after procedure)Binary variable describing amniotic fluid leakage before the onset of labor
Chorioamnionitis (yes/no)Between the procedure and birth, up to 21 weeks after procedureBinary variable describing the presence of a chorioamnionitis between the procedure and birth
Oligohydramnios without PROM (yes/no)Between the procedure and birth, up to 21 weeks after procedureBinary variable describing the presence of a oligohydramnios (deepest pool \< 2 cm) without evidence of vaginal amniotic fluid leakage
Placental abruption (yes/no)Between the procedure and birth, up to 21 weeks after procedureBinary variable describing the presence of a placental abruption
Mode of delivery (vaginal / cesarean)At birth, up to 21 weeks after procedureBinary variable describing the mode of delivery, vaginal or cesarean section
Post-operative hemoglobin (g/dL)24 hours after procedureHemoglobin level after the procedure
Acute Pulmonary edema (yes/no)Between the procedure and birth, up to 21 weeks after procedureBinary variable describing the presence of a maternal pulmonary edema, regardless of the severity, between the procedure and discharge.
Closure of the spinal defect (yes/no)Between birth and 1 month of lifeBinary variable describing the watertight closure of the defect
Maintenance of the neurological level (Better / same / worse)1 month of lifeCategorical variable describing if the postnatally assessed neurological level is better / same or worse than the level assessed prenatally before the procedure. It will be assessed by physical examination
Reversal of Chiari malformation(completely reversed / mild improvement / no improvement) by MRI1 month of lifeCategorical variable comparing the postnatal and prenatal MRI assessment of the Chiari malformation
Ventriculoperitoneal shunting (yes/no)Between birth and 12 monthsBinary variable describing the need of a ventriculoperitoneal shunting
Uterine dehiscence (yes/no)At birth, up to 21 weeks after procedureBinary variable describing the presence of a uterine dehiscence, regardless of whether it is symptomatic or it is diagnosed at the time of cesarean section
Blood transfusion (yes/no)Between procedure and discharge, up to 21 weeksBinary variable describing if a transfusion of blood derivates is carried out between the time of procedure and discharge
Gestational age at delivery (weeks and days as x/7)At birth, up to 21 weeks after procedureGestational age at birth
Surgery to delivery interval (days)At birth, up to 21 weeks after procedureInterval between surgery and birth

Countries

Spain

Contacts

Primary ContactElena Carreras, PhD
ecarreras@vhebron.net
Backup ContactNerea Maiz, PhD
nmaiz@vhebron.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026